4-[(4-Chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 4-[(4-Chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine
• 英文别名: 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine
• 化学式: C38H39ClN6O
• 分子量: 631.2
• InChiKey: JJORTRVMWNNWNP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.76
• 重原子数：
  46
• 可旋转键数：
  3
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  77.5
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• US20140343041A1
  申请人：——

  公开号：US20140343041A1

  公开（公告）日：2014-11-20
• Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache
  申请人：Ora, Inc.

  公开号：US20170042903A1

  公开（公告）日：2017-02-16

  The present invention provides topical ophthalmic formulations comprising a combination of one or more antihistamine agents and optionally one or more vasculature modifying agents such as a β adrenergic receptor antagonist. Also provided are methods of using the formulations of the invention for treating and/or preventing symptoms associated with migraine headache, and for reducing the frequency, severity and duration of migraine attacks.
• TOPICAL OPHTHALMIC FORMULATIONS FOR THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE
  申请人：Ora, Inc.

  公开号：US20180140612A1

  公开（公告）日：2018-05-24

  The present invention provides topical ophthalmic formulations comprising a combination of one or more antihistamine agents and optionally one or more vasculature modifying agents such as a β adrenergic receptor antagonist. Also provided are methods of using the formulations of the invention for treating and/or preventing symptoms associated with migraine headache, and for reducing the frequency, severity and duration of migraine attacks.
• [EN] TOPICAL OPHTHALMIC FORMULATIONS FOR TREATING MIGRAINE<br/>[FR] FORMULATIONS OPHTALMIQUES TOPIQUES POUR TRAITER LA MIGRAINE
  申请人：CHAPIN MATTHEW J

  公开号：WO2014150899A1

  公开（公告）日：2014-09-25

  The present invention provides topical ophthalmic formulations comprising a combination of one or more antihistamine agents and optionally one or more vasculature modifying agents such as a β adrenergic receptor antagonist. Also provided are methods of using the formulations of the invention for treating and/or preventing symptoms associated with migraine headache, and for reducing the frequency, severity and duration of migraine attacks.